Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med’s Autism Clinical Study
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through...
Autism
Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med’s Autism Clinical Study
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through...
Shrub Oak International School Reinforces Unwavering Commitment to Student Safety and Security
MOHEGAN LAKE, N.Y., Dec. 5, 2025 /PRNewswire/ -- Shrub Oak International School today announced enhanced details of its comprehensive, multi-layered...
LuxAI, Luxembourg Institute of Health, and University of Birmingham launch the first large-scale study of at-home, robot-led early development support for autistic children with QTrobot
LUXEMBOURG and BIRMINGHAM, England, Dec. 4, 2025 /PRNewswire/ -- LuxAI, together with the Luxembourg Institute of Health (LIH) and the...
UofL’s 2026 Grawemeyer psychology award winner recognized for contributions to autism research
LOUISVILLE, Ky., Dec. 4, 2025 /PRNewswire/ -- Sir Simon Baron-Cohen has received the 2026 Grawemeyer Award in Psychology, a distinction...
Tobinworld Calls for Early Action: Organization Urges Parents to Recognize Early Signs of Autism and Developmental Delays
Following Recent Feature, Tobinworld Highlights Why Early Awareness Can Change a Child's Future LOS ANGELES, CA / ACCESS Newswire /...
BTT Medical Institute Announces Unprecedented Case of Total Reversal of ALS through Re-engineering of the Nobel Prize-Winning Fever Therapy into a Brain-Guided, Artificial Intelligence-Controlled ThermoFebrile Treatment
First video-documented ALS reversal marks a new era for brain health achieved through noninvasive computerized brain-temperature modulation, confirmed by electrophysiological,...
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review. Assigned GDUFA goal...
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
WILMINGTON, Del., Dec. 02, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical...
NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
WILMINGTON, Del., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the “Company”, “NRx”), a clinical-stage biopharmaceutical company...
Beyond Air® Announces Transition of Chief Financial Officer
Launched search for permanent successorGARDEN CITY, N.Y., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air”...
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related...
MIRDC Wins Dual R&D 100 Awards for AI-Guided Interactive Speech-Language Therapy System
KAOHSIUNG, Nov. 24, 2025 /PRNewswire/ -- The Metal Industries Research & Development Centre (MIRDC) has been awarded two 2025 R&D...
Main Line Psychiatric Practice Expands Comprehensive Mental Health Care for Autism and ADHD
Psychiatric Associates of Pennsylvania Addresses Critical Gap in Neurodevelopmental Mental Health Services NARBERTH, PA / ACCESS Newswire / November 24,...
Main Line Psychiatric Practice Expands Comprehensive Mental Health Care for Autism and ADHD
Psychiatric Associates of Pennsylvania Addresses Critical Gap in Neurodevelopmental Mental Health Services NARBERTH, PA / ACCESS Newswire / November 24,...
ADIA Nutrition Submits Patent-Pending Autism Protocol for Independent IRB Review – Clinical Study Launch Nears
Winter Park, Florida--(Newsfile Corp. - November 24, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) announced today that, following the independent...
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat...
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development...
Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
Artisan and Tulex Report Positive Phase 2a Results for Autism Drug ART-501SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Artisan...
RethinkBH and Raintree Debut Integrated Solution for Multidisciplinary Pediatric and Behavioral Health Practices
New collaboration enables users to streamline operations, reduce administrative burden and empower practices to expand into ABA services NEW YORK,...